Literature DB >> 30963656

Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.

Annalisa Fui1, Laura Bergantini1, Enrico Selvi2, Maria A Mazzei3, David Bennett1, Maria G Pieroni1, Paola Rottoli1, Elena Bargagli1.   

Abstract

Entities:  

Keywords:  interstitial lung disease; rheumatoid arthritis; rituximab

Mesh：

Substances：

Year:  2020        PMID： 30963656     DOI： 10.1111/imj.14306

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  12 in total

Review 1.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

Review 2.  Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients.

Authors:  Riccardo Messina; Giuliana Guggino; Alida Benfante; Nicola Scichilone
Journal:  Drugs Aging       Date:  2020-01       Impact factor: 3.923

3.  Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis.

Authors:  Yuanchen Zhao; Yang Gao; Tananchai Petnak; Wisit Cheungpasitporn; Charat Thongprayoon; Xing Zhang; Teng Moua
Journal:  Respir Res       Date:  2022-06-21

Review 4.  Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Authors:  George E Fragoulis; Elena Nikiphorou; Jörg Larsen; Peter Korsten; Richard Conway
Journal:  Front Med (Lausanne)       Date:  2019-10-23

Review 5.  Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.

Authors:  Caterina Vacchi; Andreina Manfredi; Giulia Cassone; Gian Luca Erre; Carlo Salvarani; Marco Sebastiani
Journal:  Drugs Context       Date:  2021-01-15

Review 6.  Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.

Authors:  Kuang-Hui Yu; Hsin-Hua Chen; Tien-Tsai Cheng; Yeong-Jian Jan; Meng-Yu Weng; Yeong-Jang Lin; Hung-An Chen; Jui-Tseng Cheng; Kuang-Yung Huang; Ko-Jen Li; Yu-Jih Su; Pui-Ying Leong; Wen-Chan Tsai; Joung-Liang Lan; Der-Yuan Chen
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

7.  Choosing pharmacotherapy for ILD in patients with connective tissue disease.

Authors:  Zhe Wu; Philip L Molyneaux
Journal:  Breathe (Sheff)       Date:  2021-12

Review 8.  Suboptimal Humoral Immunity in Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Viral Variant Generation.

Authors:  Shiv Pillai
Journal:  Clin Lab Med       Date:  2021-11-03       Impact factor: 1.935

Review 9.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

Review 10.  Regulatory B cells in respiratory health and diseases.

Authors:  Madhvi Menon; Tracy Hussell; Halima Ali Shuwa
Journal:  Immunol Rev       Date:  2021-01-06       Impact factor: 10.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.